期刊文献+

国际医药企业购并动因分析及对中国的启示 被引量:4

Study on Motive of M&A in International Pharmaceutical Industry and Its Enlightening to China
下载PDF
导出
摘要 本文分析了国际医药企业购并的动因 ,借鉴其经验 。
作者 李萍
出处 《广东财经职业学院学报》 2002年第5期32-35,共4页 Journal of Guangdong vocational college of Finance and Economics
  • 相关文献

参考文献2

二级参考文献24

共引文献33

同被引文献19

  • 1徐爱军,陈传明.医药生产企业实施战略联盟的动因和形式探讨[J].中国卫生经济,2005,24(11):61-64. 被引量:10
  • 2邱岚.中国医药行业上市公司并购的实证研究[D].澳门大学硕士论文,2005.
  • 3Andrade G, M Mitchell ,E Staford (2001). New Evidence and Perspectives on Mergers. Journal of Economic Perspectives. 15, 103-120.
  • 4Barrett A, Capell K(2002). Big pharma: Getting too big for its own goody Business Week. July 29:74.
  • 5Brealy R A, S C Myers (2003). Principles of Corporate Finance.Irwin, McGrow-Hill, 6th edition.
  • 6Bruce Rasmussen(2002). The Role of Pharmaceutical Alliances. Centre for Strategic Economic Studies Victoria University of Technology: Pharmaceutical Industry Project Equity, Sustainability and Industry Development Working Paper Series. June.
  • 7Christopher B Kummer.(2006). mergers & Acquisition in The Pharmaceutical Industry in South America:Activity and Strategic[C] Intentions.Global Confernece on Business and Finance. San Jose, Costa Rica.
  • 8Carmine Ornaghi( 2006).Mergers and Innovation:The Case of the Pharmaceutical Industry. Discussion paper of University of Southampton: 0605.
  • 9Darren Snellgrove(2001). Pharmaceutical Mergers." What's the Rush? Drivers of Recent and Future M&A Activity. Villanova University working paper.
  • 10Erik Stalstedt & Jens Eriksson (2006). Mergers & Acquisi t ions- Abnormal returns in the pharmaceutical industry [D]. JONKOPING UNIVERSITY Bachelor Thesis in Finance.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部